Why the study?
Liver fat content and the linked rate of export of triglyceride are central to the etiology of type 2 diabetes and the cardiovascular effects of fatty liver disease.
Describes a non-invasive protocol using magnetic resonance and intralipid infusion to measure intraorgan fat and hepatic triglyceride output in humans with type 2 diabetes.
Non-invasive protocol enables repeated human measurement of liver/pancreatic fat and VLDL secretion; leaves open longitudinal cardiometabolic studies.
Liver fat content and the linked rate of export of triglyceride are central to the etiology of type 2 diabetes, as well as to the cardiovascular effects of fatty liver disease. Measurement in humans of intrahepatic and intrapancreatic fat content is described using magnetic resonance techniques and quantification of the rate of hepatic secretion of very low density lipoprotein using a non-isotopic competitive blocking of tissue uptake. This protocol is non-invasive, can be repeated sequentially, and does not involve ionizing radiation. For complete details on the use and execution of this protocol, please refer to (Taylor et al., 2018) and (Al-Mrabeh et al., 2020b).
No takes yet. Share an insight, caveat, or question.
Al-Mrabeh et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: